Serum lubricin levels in patients with juvenile idiopathic arthritis

Rabia Miray Kisla Ekinci, Sibel Balci, Fatma Coban, Atil Bisgin, Rabia Miray Kisla Ekinci, Sibel Balci, Fatma Coban, Atil Bisgin

Abstract

Objectives: Lubricin, encoded by the proteoglycan 4 (PRG4) gene, is mainly responsible for lubricating joints. However, there is expanding evidence on its involvement in inflammatory pathways. Juvenile idiopathic arthritis (JIA) is a heterogeneous group of chronic arthritides with an unknown origin in children aged below 16 years. It is characterized by chronic joint inflammation, including synovial inflammation, and may result in cartilage destruction. We aimed to determine whether serum lubricin levels are affected in JIA patients.

Material and methods: This cross-sectional study included children diagnosed with JIA and 28 healthy controls. The patients were divided into two groups according to the presence of remission at the time of study. Lubricin protein analysis was performed by the enzyme-linked immunosorbent assay method. Serum samples were obtained at the study enrollment, and lubricin levels were measured once, and compared between JIA patients and healthy controls, and between JIA patients with active disease and remission.

Results: The study included 52 JIA patients (28 female, 24 male) and 28 healthy controls (18 female, 10 males). The mean age at study enrollment was 11.66 ±4.41 years and 12.72 ±4.52 years in the JIA patient and control groups, respectively. Although median serum lubricin level did not differ between JIA patients (median: 0.66 ng/μl, range: 0.02-3.85 ng/μl) and healthy controls (median: 0.52 ng/μl, range: 0.06-3.84 ng/μl), it was statistically significantly higher in patients with active disease (median: 1.58 ng/μ, range: 0.08-3.85 ng/μl) than both patients in remission (median: 0.57 ng/μl, range: 0.02-3.57 ng/μl) and healthy controls. A low degree positive correlation was also found between serum lubricin levels and erythroid sedimentation rate of the JIA patients (r = 0.383 and p = 0.011).

Conclusions: This is the first study investigating serum lubricin levels in JIA patients, and we found elevated serum lubricin levels in JIA patients with active disease. Further studies are needed to clarify our results.

Keywords: juvenile idiopathic arthritis; lubricin; proteoglycan 4.

Conflict of interest statement

The authors declare no conflict of interest.

Copyright: © 2021 Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie.

Figures

Fig. 1
Fig. 1
Distribution of serum lubricin levels of juvenile idiopathic arthritis patients during active disease, remission and healthy controls

References

    1. Schumacher BL, Block JA, Schmid TM, et al. A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage. Arch Biochem Biophys. 1994;311:144–152. doi: 10.1006/abbi.1994.1219.
    1. Schumacher BL, Schmidt TA, Voegtline MS, et al. Proteoglycan 4 (PRG4) synthesis and immunolocalization in bovine meniscus. J Orthop Res. 2005;23:562–568. doi: 10.1016/j.orthres.2004.11.011.
    1. Flannery CR, Zollner R, Corcoran C, et al. Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin. Arthritis Rheum. 2009;60:840–847. doi: 10.1002/art.24304.
    1. Kosinska MK, Ludwig TE, Liebisch G, et al. Articular joint lubricants during osteoarthritis and rheumatoid arthritis display altered levels and molecular species. PLoS One. 2015;10:e0125192. doi: 10.1371/journal.pone.0125192.
    1. Estrella RP, Whitelock JM, Packer NH, Karlsson NG. The glycosylation of human synovial lubricIn: implications for its role in inflammation. Biochem J. 2010;429:359–367. doi: 10.1042/BJ20100360.
    1. Alquraini A, Garguilo S, D’Souza G, et al. The interaction of lubricin/proteoglycan 4 (PRG4) with toll-like receptors 2 and 4: an anti-inflammatory role of PRG4 in synovial fluid. Arthritis Res Ther. 2015;17:353. doi: 10.1186/s13075-015-0877-x.
    1. Al-Sharif A, Jamal M, Zhang LX, et al. Lubricin/proteoglycan 4 binding to cd44 receptor: a mechanism of the suppression of proinflammatory cytokine-induced synoviocyte proliferation by lubricin. Arthritis Rheumatol. 2015;67:1503–1513. doi: 10.1002/art.39087.
    1. Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile idiopathic arthritis. Balkan Med J. 2017;34:90–101. doi: 10.4274/balkanmedj.2017.0111.
    1. Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377:2138–2149. doi: 10.1016/S0140-6736(11)60244-4.
    1. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–392.
    1. Wallace CA, Giannini EH, Huang B, et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2011;63:929–936. doi: 10.1002/acr.20497.
    1. Kisla Ekinci RM, Balci S, Dogan H, et al. Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome resembling juvenile idiopathic arthritis: a single-center experience from southern Turkey. Mol Syndromol. 2021;12:112–117. doi: 10.1159/000513111.
    1. Yilmaz S, Uludağ Alkaya D, Kasapçopur Ö, et al. Genotype-phenotype investigation of 35 patients from 11 unrelated families with Camptodactyly-Arthropathy-Coxa Vara-Pericarditis (CACP) Syndrome. Mol Genet Genomic Med. 2018;6:230–248. doi: 10.1002/mgg3.364.
    1. Kamphuis S, Hrafnkelsdóttir K, Klein MR, et al. Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health. Arthritis Res Ther. 2006;8:R178. doi: 10.1186/ar2088.
    1. Winsz-Szczotka K, Kuźnik-Trocha K, Komosińska-Vassev K, et al. Laboratory indicators of aggrecan turnover in juvenile idiopathic arthritis. Dis Markers. 2016;2016:7157169. doi: 10.1155/2016/7157169.
    1. Winsz-Szczotka K, Komosińska-Vassev K, Kuźnik-Trocha K, et al. Circulating keratan sulfate as a marker of metabolic changes of cartilage proteoglycan in juvenile idiopathic arthritis; influence of growth factors as well as proteolytic and prooxidative agents on aggrecan alterations. Clin Chem Lab Med. 2015;53:291–297. doi: 10.1515/cclm-2014-0441.
    1. Wojdas M, Dąbkowska K, Winsz-Szczotka K. Alterations of extracellular matrix components in the course of juvenile idiopathic arthritis. Metabolites. 2021;11:132. doi: 10.3390/metabo11030132.
    1. Vynios DH. Metabolism of cartilage proteoglycans in health and disease. Biomed Res Int. 2014;2014:452315. doi: 10.1155/2014/452315.
    1. Shigemori M, Takei S, Imanaka H, et al. Diagnostic significance of increased serum hyaluronic acid in juvenile rheumatoid arthritis. Pediatr Int. 2002;44:394–399. doi: 10.1046/j.1442-200x.2002.01586.x.
    1. Iqbal SM, Leonard C, Regmi SC, et al. Lubricin/Proteoglycan 4 binds to and regulates the activity of toll-like receptors in vitro. Sci Rep. 2016;6:18910. doi: 10.1038/srep18910.
    1. Jin C, Ekwall AK, Bylund J, et al. Human synovial lubricin expresses sialyl Lewis x determinant and has L-selectin ligand activity. J Biol Chem. 2012;287:35922–35933. doi: 10.1074/jbc.M112.363119.
    1. Ai M, Cui Y, Sy M-S, et al. Anti-lubricin monoclonal antibodies created using lubricin-knockout mice immunodetect lubricin in several species and in patients with healthy and diseased joints. PLoS One. 2015;10:e0116237. doi: 10.1371/journal.pone.0116237.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera